|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23577190; geneId=84159; geneSymbol=ARID5B; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242909916; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=22446963; geneId=4794; geneSymbol=NFKBIE; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Our study identified nine loci newly associated with rheumatoid arthritis at a threshold of P < 5.0 ¡Á 10(-8), including B3GNT2, ANXA3, CSF2, CD83, NFKBIE, ARID5B, PDE2A-ARAP1, PLD4 and PTPN2.; score=0.245005506; Year=2012; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23577190; geneId=1437; geneSymbol=CSF2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.129424521; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23577190; geneId=116985; geneSymbol=ARAP1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.000271442; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23577190; geneId=306; geneSymbol=ANXA3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23577190; geneId=7128; geneSymbol=TNFAIP3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.167568474; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2240335 |
SNP |
PedAM |
snpId=rs2240335; pubmedId=21452313; geneId=23569; geneSymbol=PADI4; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Genome-wide association study of rheumatoid arthritis in Koreans: population-specific loci as well as overlap with European susceptibility loci.; score=0.33168498; Year=2011; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17348042; REF=C; ALT=A |
details
|
|
|
rs2240335 |
SNP |
PedAM |
snpId=rs2240335; pubmedId=21505073; geneId=23569; geneSymbol=PADI4; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=The human AIRE gene at chromosome 21q22 is a genetic determinant for the predisposition to rheumatoid arthritis in Japanese population.; score=0.33168498; Year=2011; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17348042; REF=C; ALT=A |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=23577190; geneId=1437; geneSymbol=CSF2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.129424521; Year=2013; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=23577190; geneId=10678; geneSymbol=B3GNT2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123181358; Year=2013; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=23577190; geneId=306; geneSymbol=ANXA3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=23577190; geneId=116985; geneSymbol=ARAP1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.000271442; Year=2013; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=23577190; geneId=84159; geneSymbol=ARID5B; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242909916; Year=2013; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=23577190; geneId=7128; geneSymbol=TNFAIP3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.167568474; Year=2013; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=23577190; geneId=9034; geneSymbol=CCRL2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.005710211; Year=2013; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=23577190; geneId=5771; geneSymbol=PTPN2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.248458305; Year=2013; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=22505706; geneId=23569; geneSymbol=PADI4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=These findings suggest that the functional single-nucleotide polymorphism PADI4 rs2240340 G/A variant allele is associated with RA development, especially among older patients and ACPA-positive patients.; score=0.33168498; Year=2012; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=23577190; geneId=122618; geneSymbol=PLD4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2240340 |
SNP |
PedAM |
snpId=rs2240340; pubmedId=23577190; geneId=9308; geneSymbol=CD83; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123267234; Year=2013; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17336144; REF=T; ALT=C |
details
|
|
|
rs2243115 |
SNP |
PedAM |
snpId=rs2243115; pubmedId=25469793; geneId=3592; geneSymbol=IL12A; diseaseId=umls:C0003873; sourceId=BeFree; sentence=No significant association was observed between rs2243115 in IL-12A and RA, due probably to the limited power.; score=0.000542884; Year=2014; geneSymbol_dbSNP=IL12A;IL12A-AS1; CHROMOSOME=3; POS=159988493; REF=T; ALT=G |
details
|
|
